About the cBioPortal

The cBioPortal for Cancer Genomics is a resource designed to provide broad community access to cancer genomic data. It provides a unique user­-friendly and "biology­-centric computational user interface", with the goal of making genomic data more easily accessible to translational scientists, biologists, and clinicians. The interface was explicitly built and continues to evolve with careful usability studies involving multiple biological and clinical users, and an active and engaged user base.

The public cBioPortal is now one of the most popular resources for cancer genomics data and attracts more than 3,000 cancer researchers and clinicians per day. The cBioPortal paper (Cerami et al. Cancer Discov. 2012 has been cited more than 4,000 times since its publication.

The cBioPortal project has become an open source project under the Affero General Public License (AGPL), due to the high demand for local installations and contribution requests. There are more than 40 actively used cBioPortal instances in hospitals, universities, pharmaceutical companies, and other institutes all over the globe.

About us

We are a group of software engineers, bioinformaticians, and cancer biologists building software solutions for precision medicine for cancer patients. Our overall goal is to build infrastructure to support clinical decisions for personalized cancer treatment by utilizing “big data” of cancer genomics and patient clinical profiles. Our multi-institutional team currently has more than 30 active members, primarily from Memorial Sloan Kettering Cancer Center in New York, the Dana-Farber Cancer Institute in Boston, Princess Margaret Cancer Centre in Toronto, Children's Hospital of Philadelphia, and The Hyve, a bioinformatics company from the Netherlands.